pfizer inc
Pfizer’s Pneumonia Vaccine Patent Challenged In India
Pfizer’s pneumonia vaccine patent has come under legal challenge in India.
DKSH To Support Pfizer’s Expansion In Laos
DKSH has been appointed as Pfizer's market expansion service provider for Laos.
MSD Joins A*STAR’s Manufacturing Consortium
Pharmaceutical giant MSD is the latest member of A*STAR's iPSP, a program to boost productivity in the high value chemistry sector.
Pfizer Awards US$850,000 Grant To Combat Smoking In China
The grant builds on tobacco control work in China previously funded by the Bill and Melinda Gates Foundation.
Pharmaceutical IT Asia Congress To Highlight Digital Healthcare Innovation
Oxford Global’s Pharmaceutical IT Asia Congress will take place from March 25-26, 2014 in Singapore..
Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan
Pfizer and Takeda Pharmaceutical have launched their rheumatoid arthritis drug XELJANZ® (tofacitinib citrate) in Japan.
Pfizer To Conduct NSCLC Drug Trial In Asia
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.
Pfizer, Mylan To Team Up On Generics Business In Japan
Pfizer Inc. and Mylan Inc. have signed an agreement to develop, manufacture, distribute, and market generic drugs in Japan.
Pfizer & Hisun Pharma To Jointly Develop Off-Patent Generics In China
Pfizer Inc. and Zhejiang Hisun Pharmaceutical have agreed to jointly develop, manufacture, and commercialize off-patent pharmaceutical products in China and global markets.
Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020
A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.
